Press Releases

Press Releases

Dec 15, 2010
BRIDGEWATER, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced the initiation of Phase I clinical studies, in collaboration with the National Cancer Institute (NCI), for two of the Company's novel oncology product candidates, EZN-2968 and EZN-2208 (PEG-SN38).
Nov 17, 2010
Third-Generation mRNA-Targeting Compounds Show Potent Anti-Tumor Activity BRIDGEWATER, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists.
Nov 2, 2010
BRIDGEWATER, N.J., Nov 02, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the third quarter of 2010.
Nov 2, 2010
BRIDGEWATER, N.J., Nov 02, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.
Oct 29, 2010
BRIDGEWATER, N.J., Oct 29, 2010 (BUSINESS WIRE) -- Second graph of release, the time zones should be CET. (sted, CEST).
Oct 29, 2010
BRIDGEWATER, N.J., Oct 29, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.
Oct 26, 2010
BRIDGEWATER, N.J., Oct 26, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended September 30, 2010, on Tuesday, November 2, 2010. The Company will also conduct a conference call that day at 4:00 p.m.
Oct 5, 2010
BRIDGEWATER, N.J., Oct 05, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc.
Aug 3, 2010
BRIDGEWATER, N.J., Aug 03, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the second quarter of 2010.
Jul 28, 2010
BRIDGEWATER, N.J., Jul 28, 2010 (BUSINESS WIRE) -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended June 30, 2010, on Tuesday, August 3, 2010 at 4:00 pm Eastern Time (ET).